Abstract
Gαs and extra-large Gαs (XLαs) can both transduce receptor activation into intracellular cAMP generation. It is unknown, however, whether these two GNAS-locus products display distinct properties with respect to receptor coupling. Here, we show that XLαs couples to the β2-adrenoceptor more efficiently than Gαs. In transfected human embryonic kidney 293 cells and mouse embryonic fibroblasts null for both Gαs and XLαs (2B2 cells), basal cAMP accumulation mediated by XLαs was higher than that mediated by Gαs. Inverse agonist treatment reduced Gαs-mediated basal activity, whereas its effect was markedly blunted on XLαs-mediated basal activity. Rank order of ligand efficacies regarding cAMP accumulation was the same when the receptor was coupled to XLαs or Gαs. However, ligand-induced and XLαs-mediated cAMP generation was higher than that mediated by Gαs. The relatively high efficiency of XLαs-mediated cAMP generation was conditional, disappearing with increased level of receptor expression or increased efficacy of ligand. Full-agonist responses in XLαs- and Gαs-expressing cells were comparable even at low receptor levels, whereas partial agonist responses became comparable only when the receptor expression was increased (>3 pmol/mg). Radioligand binding studies showed that the high-affinity component in agonist binding to β2-adrenoceptor was more pronounced in cells expressing XLαs than those expressing Gαs. We discuss these findings in the framework of current receptor-G protein activation models and offer an extended ternary complex model that can fully explain our observations.
Footnotes
-
This work was supported in part by the Turkish Scientific and Technical Research Council [Grants 104s472, 107s086]; the Ankara University Research Fund [Grant BAP 2002 0809 088]; the Ankara University Biotechnology Institute [Grant 103]; and the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grant R01-DK073911].
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.108.149989.
-
ABBREVIATIONS: XLαs, extra-large Gαs; GTPγS, guanosine 5′-O-(3-thio)triphosphate; GαsL,Gαs long form; βAR, β2-adrenoceptor; HEK, human embryonic kidney; DMEM, Dulbecco's modified Eagle's medium; PBS, phosphate-buffered saline; MTT, methylthiazolyldiphenyl-tetrazolium bromide; ICI-188,551; (±)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol; ICI-89,406, N-(2-((3-(2-cyanophenoxy)-2-hydroxypropyl)amino)ethyl)-N′-phenylurea.
-
↵ The online version of this article (available at http://jpet.aspetjournals.org) contains supplemental material.
-
↵1 Current affiliation: Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina.
- Received December 17, 2008.
- Accepted January 12, 2009.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|